John E. Sagartz

2.6k total citations
43 papers, 1.8k citations indexed

About

John E. Sagartz is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, John E. Sagartz has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in John E. Sagartz's work include Virus-based gene therapy research (10 papers), Veterinary Oncology Research (5 papers) and Cancer-related Molecular Pathways (5 papers). John E. Sagartz is often cited by papers focused on Virus-based gene therapy research (10 papers), Veterinary Oncology Research (5 papers) and Cancer-related Molecular Pathways (5 papers). John E. Sagartz collaborates with scholars based in United States, United Kingdom and Japan. John E. Sagartz's co-authors include Dale L. Morris, Jeffrey A. Kramer, R. Mark L. Buller, Charles C. Capen, Jacqueline F. Spencer, William S.M. Wold, Károly Tóth, Sissy Jhiang, Jan Parker‐Thornburg and C. Ledent and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Nature Reviews Drug Discovery.

In The Last Decade

John E. Sagartz

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Sagartz United States 26 651 461 423 373 269 43 1.8k
Carol J. Detrisac United States 24 922 1.4× 198 0.4× 367 0.9× 111 0.3× 78 0.3× 47 1.8k
Jeremy O. Jones United States 24 783 1.2× 433 0.9× 293 0.7× 192 0.5× 156 0.6× 73 1.9k
Farida Sarangi Canada 23 1.6k 2.5× 897 1.9× 576 1.4× 590 1.6× 266 1.0× 31 3.0k
J. George Bekesi United States 25 708 1.1× 258 0.6× 115 0.3× 198 0.5× 73 0.3× 96 1.9k
Ilze Matise United States 21 945 1.5× 300 0.7× 263 0.6× 79 0.2× 59 0.2× 41 1.6k
John Guardiola Italy 31 1.0k 1.6× 311 0.7× 345 0.8× 238 0.6× 112 0.4× 116 3.0k
Jerry A. Peterson United States 27 1.5k 2.2× 407 0.9× 386 0.9× 301 0.8× 175 0.7× 72 3.2k
Nadine L. Dudek Australia 26 900 1.4× 407 0.9× 691 1.6× 480 1.3× 287 1.1× 42 3.9k
Sean Kim United States 17 991 1.5× 815 1.8× 369 0.9× 295 0.8× 136 0.5× 26 4.5k
Akiko Sakurai Japan 21 498 0.8× 135 0.3× 119 0.3× 160 0.4× 105 0.4× 72 1.5k

Countries citing papers authored by John E. Sagartz

Since Specialization
Citations

This map shows the geographic impact of John E. Sagartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Sagartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Sagartz more than expected).

Fields of papers citing papers by John E. Sagartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Sagartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Sagartz. The network helps show where John E. Sagartz may publish in the future.

Co-authorship network of co-authors of John E. Sagartz

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Sagartz. A scholar is included among the top collaborators of John E. Sagartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Sagartz. John E. Sagartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lomonosova, Elena, Qilan Li, Ryan P. Murelli, et al.. (2017). Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice. Antiviral Research. 149. 41–47. 31 indexed citations
2.
Tóth, Károly, Baoling Ying, Jacqueline F. Spencer, et al.. (2015). STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control. PLoS Pathogens. 11(8). e1005084–e1005084. 43 indexed citations
3.
Eickhoff, Christopher S., et al.. (2013). Lethal NK-mediated inflammation induced by IL-12 in the absence of polymorphic and nonpolymorphic MHC class I molecules. Cytokine. 64(1). 25–29. 2 indexed citations
4.
Parker, Scott, Nanhai G. Chen, Scott A. Foster, et al.. (2012). Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox – An animal model of smallpox. Antiviral Research. 94(1). 44–53. 42 indexed citations
5.
Eickhoff, Christopher S., et al.. (2010). ECG Detection of Murine Chagasic Cardiomyopathy. Journal of Parasitology. 96(4). 758–764. 40 indexed citations
6.
Stabenow, Jennifer, et al.. (2010). A Mouse Model of Lethal Infection for Evaluating Prophylactics and Therapeutics against Monkeypox Virus. Journal of Virology. 84(8). 3909–3920. 85 indexed citations
7.
Vijayalingam, S., et al.. (2010). Overexpression of BH3-Only Protein BNIP3 Leads to Enhanced Tumor Growth. Genes & Cancer. 1(9). 964–971. 25 indexed citations
8.
Spencer, Jacqueline F., John E. Sagartz, William S.M. Wold, & Károly Tóth. (2009). New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster. Cancer Gene Therapy. 16(12). 912–922. 27 indexed citations
9.
Thomas, Maria, Jacqueline F. Spencer, Károly Tóth, et al.. (2008). Immunosuppression Enhances Oncolytic Adenovirus Replication and Antitumor Efficacy in the Syrian Hamster Model. Molecular Therapy. 16(10). 1665–1673. 97 indexed citations
10.
Schultz, Denise, John E. Sagartz, David L. Huso, & R. Mark L. Buller. (2008). Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. Virology. 383(1). 86–92. 60 indexed citations
11.
Stabenow, Jennifer, et al.. (2008). An immunosuppressed Syrian golden hamster model for SARS-CoV infection. Virology. 380(2). 312–321. 48 indexed citations
12.
Kramer, Jeffrey A., John E. Sagartz, & Dale L. Morris. (2007). The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates. Nature Reviews Drug Discovery. 6(8). 636–649. 241 indexed citations
13.
Cho, Je‐Yoel, John E. Sagartz, Charles C. Capen, Ernest L. Mazzaferri, & Sissy Jhiang. (1999). Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice. Oncogene. 18(24). 3659–3665. 48 indexed citations
14.
Jhiang, Sissy, et al.. (1998). Thyroid Carcinomas in RET/PTC Transgenic Mice. Recent results in cancer research. 154. 265–270. 45 indexed citations
15.
Gamblin, Rance M., John E. Sagartz, & C. Guillermo Couto. (1997). Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. American Journal of Veterinary Research. 58(8). 857–863. 46 indexed citations
16.
Constable, Peter D., et al.. (1996). Suspected cerebrospinal parasitism with subsequent disseminated phycomycosis and bacterial infection in an alpaca (Lama pacos). Journal of Zoo and Wildlife Medicine. 27(3). 402–408. 1 indexed citations
17.
Sagartz, John E., et al.. (1996). Lymphangiosarcoma in a Young Dog. Veterinary Pathology. 33(3). 353–356. 29 indexed citations
18.
Sagartz, John E., et al.. (1995). Systemic Mastocytosis in a Goat. Veterinary Pathology. 32(6). 719–721. 7 indexed citations
19.
Sagartz, John E., et al.. (1995). Phagocytic Activity of FRTL-5 Rat Thyroid Follicular Cells as Measured by Ingestion of Fluorescent Latex Beads. Experimental Cell Research. 219(2). 547–554. 6 indexed citations
20.
Sagartz, John E. & David E. Swayne. (1991). INCLUSION BODY HEPATITIS IN A PIGEON ASSOCIATED WITH AN ADENOVIRUS. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol J. Detrisac Breakdown of academic impact, for papers by Jeremy O. Jones Breakdown of academic impact, for papers by Farida Sarangi Breakdown of academic impact, for papers by J. George Bekesi Breakdown of academic impact, for papers by Ilze Matise Breakdown of academic impact, for papers by John Guardiola Breakdown of academic impact, for papers by Jerry A. Peterson Breakdown of academic impact, for papers by Nadine L. Dudek Breakdown of academic impact, for papers by Sean Kim Breakdown of academic impact, for papers by Akiko Sakurai
Rankless by CCL
2026